Shifa Kanjwal, MD
Medical Oncology Physician · Dallas, TX
Shifa Kanjwal, MD is a medical oncology physician with a practice address in Dallas, Texas, and NPI 1982131256, issued on May 17, 2017. Check the license (Texas S5943, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Shifa Kanjwal
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- S5943 TX
Self-reported in NPPES; status is on the state search - Practice location
- 6202 Harry Hines Blvd, Dallas, TX 75390
- Phone
- (214) 645-3999
- Enumerated
- May 17, 2017
- Record last updated
- Sep 3, 2024
- Medicare enrollment
- Enrolled (PECOS I20200731001387); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Also registered at 6202 Harry Hines Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Daniel Addison, M.D.Cardiovascular Disease Physician1598091092
- Samer Al Hadidi, M.DHematology & Oncology Physician1245670173
- Santiago Alvarez Arango, MD, PHDAllergy & Immunology Physician1881005437
- Shukaib Arslan, M.D.Hematology & Oncology Physician1477867877
- Yu Cao, MDMedical Oncology Physician1942566070
- Victoria Chung, D.O.Hematology & Oncology Physician1568997229
Verify Shifa Kanjwal in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license S5943Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
88% fewer Medicare Part D claims than the average medical oncology physician in 2024
82 Medicare Part D claims for 22 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims.
Most prescribed
- Prochlorperazine Maleate11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $14.49
1 payment: food and beverage; the largest payer was Stemline Therapeutics Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University OF Texas Southwestern Medical Center AT DallasDallas, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Shifa Kanjwal among 547 medical oncology physician records in Texas
Shifa Kanjwal, MD is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2017, is newer than 94% of them.
- NPI issued2017 · 94% of these records are older, 5% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated2017 · median 2000 among the 414 with a school on file
- Record last updated2024 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in Dallas → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Salwan Al Mutar, M.DDallas, TX 753901508285313
- Carlos Arteaga, MDDallas, TX 753901902980014
- Yu Cao, MDDallas, TX 753901942566070
- Suzanne Conzen, MDDallas, TX 753901518029073
- David Gerber, M.D.Dallas, TX 753901336295039
- Joshua Gruber, M.D.Dallas, TX 753901437441904
- Hans Hammers, M.D., PH.D.Dallas, TX 753901851437909
- David Hsieh, M.D.Dallas, TX 753901396184354
Common questions
What is Shifa Kanjwal, MD's NPI number?
Shifa Kanjwal, MD's National Provider Identifier (NPI) is 1982131256, issued on May 17, 2017. An NPI identifies a provider in billing; it is not a license.
Where is Shifa Kanjwal, MD located?
The NPPES record lists a practice address at 6202 Harry Hines Blvd, Dallas, TX, 75390. Phone: (214) 645-3999. Providers update this record themselves, so call before visiting.
How can I verify Shifa Kanjwal, MD's license?
NPPES lists Texas license number S5943, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Shifa Kanjwal, MD prescribe under Medicare Part D?
In 2024, Shifa Kanjwal, MD had 82 Medicare Part D claims for 22 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.